Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy
- PMID: 9771710
- DOI: 10.1038/2470
Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy
Abstract
Lafora's disease (LD; OMIM 254780) is an autosomal recessive form of progressive myoclonus epilepsy characterized by seizures and cumulative neurological deterioration. Onset occurs during late childhood and usually results in death within ten years of the first symptoms. With few exceptions, patients follow a homogeneous clinical course despite the existence of genetic heterogeneity. Biopsy of various tissues, including brain, revealed characteristic polyglucosan inclusions called Lafora bodies, which suggested LD might be a generalized storage disease. Using a positional cloning approach, we have identified at chromosome 6q24 a novel gene, EPM2A, that encodes a protein with consensus amino acid sequence indicative of a protein tyrosine phosphatase (PTP). mRNA transcripts representing alternatively spliced forms of EPM2A were found in every tissue examined, including brain. Six distinct DNA sequence variations in EPM2A in nine families, and one homozygous microdeletion in another family, have been found to cosegregate with LD. These mutations are predicted to cause deleterious effects in the putative protein product, named laforin, resulting in LD.
Similar articles
-
Isolation and characterization of mouse homologue for the human epilepsy gene, EPM2A.Biochem Biophys Res Commun. 1999 Apr 2;257(1):24-8. doi: 10.1006/bbrc.1999.0402. Biochem Biophys Res Commun. 1999. PMID: 10092504
-
Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.Mol Cell Probes. 2001 Oct;15(5):281-9. doi: 10.1006/mcpr.2001.0371. Mol Cell Probes. 2001. PMID: 11735300
-
Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy.J Hum Genet. 2003;48(1):51-4. doi: 10.1007/s100380300006. J Hum Genet. 2003. PMID: 12560877
-
[Molecular genetics of epilepsy].Rinsho Shinkeigaku. 2004 Nov;44(11):858-60. Rinsho Shinkeigaku. 2004. PMID: 15651314 Review. Japanese.
-
Advances in the genetics of progressive myoclonus epilepsy.Am J Med Genet. 2001 Summer;106(2):129-38. doi: 10.1002/ajmg.1575. Am J Med Genet. 2001. PMID: 11579433 Review.
Cited by
-
E3 ubiquitin ligases in protein quality control mechanism.Mol Neurobiol. 2012 Jun;45(3):571-85. doi: 10.1007/s12035-012-8273-x. Epub 2012 May 19. Mol Neurobiol. 2012. PMID: 22610945 Review.
-
Differences in local population history at the finest level: the case of the Estonian population.Eur J Hum Genet. 2020 Nov;28(11):1580-1591. doi: 10.1038/s41431-020-0699-4. Epub 2020 Jul 25. Eur J Hum Genet. 2020. PMID: 32712624 Free PMC article.
-
Genotypes and phenotypes of patients with Lafora disease living in Germany.Neurol Res Pract. 2019;1:34. doi: 10.1186/s42466-019-0040-2. Epub 2019 Nov 12. Neurol Res Pract. 2019. PMID: 32587944 Free PMC article.
-
Malin regulates Wnt signaling pathway through degradation of dishevelled2.J Biol Chem. 2012 Feb 24;287(9):6830-9. doi: 10.1074/jbc.M111.315135. Epub 2012 Jan 5. J Biol Chem. 2012. PMID: 22223637 Free PMC article.
-
Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age.Mol Neurobiol. 2020 Mar;57(3):1607-1621. doi: 10.1007/s12035-019-01842-z. Epub 2019 Dec 5. Mol Neurobiol. 2020. PMID: 31808062 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials